We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Papillomavirus Linked to Oropharyngeal Cancer in Young Adults

By LabMedica International staff writers
Posted on 10 Oct 2013
The human papillomavirus (HPV) may be to blame for the alarming increase in the incidence of young adults with oropharyngeal cancer. More...


The epidemiological trends have been analyzed for some head and neck cancers, including those that affect the base of tongue, tonsils, soft palate, and pharynx, among people 45 years-old and younger.

Scientists at the Henry Ford Hospital (Detroit, MI, USA) used the Surveillance Epidemiology and End Results (SEER) database to gather information about adults younger than age 45 who had been diagnosed with invasive squamous cell oropharyngeal cancer between1973 and 2009. Among the study group of more than 1,600 patients, 90% were ages 36 to 44 and the majority was Caucasian (73%).

The majority of patients underwent surgical resection for their tumors. Patients who had both surgery and radiation therapy had the highest five-year survival rate. The five-year survival for the study group was 54%. There was no difference in survival based on gender. However, African Americans had significantly poor survival compared to other races. Recent medical studies has shown that HPV exposure and infection increases the risk of oropharyngeal squamous cell cancer independently of tobacco and alcohol use, two other important risk factors for the disease, according to the US National Cancer Institute (Bethesda, MD, USA).

Farzan Siddiqui, MD, PhD, director of the Head and Neck Radiation Therapy Program in the Department of Radiation Oncology at Henry Ford Hospital, said, “The growing incidence in oropharyngeal cancer has been largely attributed to the sexual revolution of the 1960s and 1970s, which led to an increased transmission of high-risk HPV. We were interested in looking at people born during that time period and incidence of oropharyngeal cancer.”

Dr. Siddiqui added, “Not only were we surprised to find a substantial increase in young adults with cancer of the tonsils and base of tongue, but also a wide deviation among Caucasians and African Americans with this cancer. The predominance of oropharyngeal cancer in this age group suggests either nonsexual modes of HPV transfer at a younger age or a shortened latency period between infection and development of cancer.” The study was presented at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) held September 22–25, 2013, in Atlanta (GA, USA).

Related Links:
Henry Ford Hospital
US National Cancer Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Electrolyte Analyzer
BKE-B
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.